In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Anavex Life Sciences Corporation (NASDAQ: AVXL) was $3.75 for the day, up 2.18% from the previous closing price of $3.67. In other words, the price has increased by $2.18 from its previous closing price. On the day, 2.56 million shares were traded. AVXL stock price reached its highest trading level at $3.82 during the session, while it also had its lowest trading level at $3.582.
Ratios:
Our analysis of AVXL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.60 and its Current Ratio is at 11.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.
On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.
On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 335055392 and an Enterprise Value of 232478400.
Stock Price History:
The Beta on a monthly basis for AVXL is 1.17, which has changed by -0.66237354 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, AVXL has reached a high of $14.44, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is -36.19%, while the 200-Day Moving Average is calculated to be -55.80%.
Shares Statistics:
AVXL traded an average of 2.50M shares per day over the past three months and 2494200 shares per day over the past ten days. A total of 86.67M shares are outstanding, with a floating share count of 86.46M. Insiders hold about 3.23% of the company’s shares, while institutions hold 36.62% stake in the company. Shares short for AVXL as of 1764288000 were 25139901 with a Short Ratio of 10.05, compared to 1761868800 on 26664141. Therefore, it implies a Short% of Shares Outstanding of 25139901 and a Short% of Float of 29.330000000000002.
Earnings Estimates
At present, 2.0 analysts are actively evaluating the performance of Anavex Life Sciences Corporation (AVXL) in the stock market.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.11 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.46 and -$0.5 for the fiscal current year, implying an average EPS of -$0.48. EPS for the following year is $1.27, with 1.0 analysts recommending between $1.27 and $1.27.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $222.04M in the next fiscal year. The high estimate is $222.04M and the low estimate is $222.04M.
